左炔诺孕酮宫内节育系统的安全性、有效性及患者可接受性综述。
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.
作者信息
Kailasam Chandra, Cahill David
机构信息
Bristol Centre for Reproductive Medicine, Southmead Hospital, Bristol, UK;
出版信息
Patient Prefer Adherence. 2008 Feb 2;2:293-302. doi: 10.2147/ppa.s3464.
Abstract
The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a common side effect, proper counseling improves compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial protection.
摘要
含左炔诺孕酮宫内节育系统是一种极其有效、可逆且安全的长效可逆避孕方式。鉴于其有效性，它是绝育等永久性避孕方法的更安全替代方案。在禁忌使用含雌激素避孕药的情况下，它尤其有用。虽然月经紊乱是常见的副作用，但适当的咨询可提高依从性。除了避孕作用外，左炔诺孕酮宫内节育系统在其他临床情况下还具有潜在的治疗益处，包括月经过多、有症状的子宫肌瘤、子宫内膜异位症和子宫内膜保护。
相似文献
1
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的安全性、有效性及患者可接受性综述。
Patient Prefer Adherence. 2008 Feb 2;2:293-302. doi: 10.2147/ppa.s3464.
2
The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.左炔诺孕酮宫内节育系统：避孕及非避孕用途的最新综述
Clin Obstet Gynecol. 2007 Dec;50(4):886-97. doi: 10.1097/GRF.0b013e318159c0d9.
3
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
4
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.左炔诺孕酮宫内节育器作为一种具有治疗特性的避孕方法。
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
5
Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.《加拿大避孕共识》（共四部分之第三部分）：第7章——宫内避孕法
J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26.
6
Hormonal intrauterine devices.激素宫内节育器
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.
7
The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.左炔诺孕酮宫内节育系统：安全性、疗效和患者可接受性。
Ther Clin Risk Manag. 2009 Jun;5(3):561-74. doi: 10.2147/tcrm.s5624. Epub 2009 Aug 3.
8
Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.左炔诺孕酮宫内节育器治疗中国女性月经过多：疗效与可接受性对比
Contraception. 1995 Apr;51(4):231-5. doi: 10.1016/0010-7824(95)00038-c.
9
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.左炔诺孕酮宫内节育系统与炔诺酮治疗特发性月经过多的随机对照试验
Br J Obstet Gynaecol. 1998 Jun;105(6):592-8. doi: 10.1111/j.1471-0528.1998.tb10172.x.
10
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识（共4部分，第1部分）
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.
引用本文的文献
1
Evaluation of the Levonorgestrel-Releasing Intrauterine System Following Difficult Insertion in Perimenopausal Women: A Case Report.围绝经期女性困难置入左炔诺孕酮宫内节育系统后的评估：一例报告
Cureus. 2025 Aug 15;17(8):e90186. doi: 10.7759/cureus.90186. eCollection 2025 Aug.
2
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers.长效、基于孕激素的避孕药与乳腺癌、妇科癌症及其他癌症的风险
J Natl Cancer Inst. 2025 May 1;117(5):1046-1055. doi: 10.1093/jnci/djae282.
3
The Effect of the Levonorgestrel-Releasing Intrauterine System on Myometrial Blood Flow in Patients With Heavy Menstrual Bleeding.左炔诺孕酮宫内节育系统对月经过多患者子宫肌层血流的影响。
Cureus. 2024 Aug 12;16(8):e66712. doi: 10.7759/cureus.66712. eCollection 2024 Aug.
4
The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.激素避孕的使用对5-羟色胺能神经传递及抗抑郁治疗反应的影响：NeuroPharm 1研究结果
Front Endocrinol (Lausanne). 2022 Mar 11;13:799675. doi: 10.3389/fendo.2022.799675. eCollection 2022.
5
Hypogonadism in Women with Prader-Willi Syndrome-Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion.普拉德-威利综合征女性的性腺功能减退——基于荷兰队列研究、文献综述及国际专家小组讨论的临床建议
J Clin Med. 2021 Dec 10;10(24):5781. doi: 10.3390/jcm10245781.
6
Vasculitis associated with the use of an intrauterine device: A case report.与宫内节育器使用相关的血管炎：一例报告。
Exp Ther Med. 2021 Nov;22(5):1277. doi: 10.3892/etm.2021.10712. Epub 2021 Sep 8.
7
Comparing options for females seeking permanent contraception in high resource countries: a systematic review.高资源国家中寻求永久避孕的女性的选择比较：一项系统综述
Reprod Health. 2021 Jul 20;18(1):154. doi: 10.1186/s12978-021-01201-z.
8
Estrogens in polycystic liver disease: A target for future therapies?多囊肝疾病中的雌激素：未来治疗的靶点？
Liver Int. 2021 Sep;41(9):2009-2019. doi: 10.1111/liv.14986. Epub 2021 Jul 10.
9
Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review.左炔诺孕酮宫内节育系统作为未生育女性的避孕方法：一项系统评价。
J Clin Med. 2020 Jul 3;9(7):2101. doi: 10.3390/jcm9072101.
10
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.经前烦躁障碍（PMDD）女性的避孕咨询：当前观点
Open Access J Contracept. 2019 Sep 20;10:27-39. doi: 10.2147/OAJC.S183193. eCollection 2019.
本文引用的文献
1
The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.左炔诺孕酮宫内节育系统（LNG-IUS）治疗子宫内膜增生的有效性——一项长期随访研究。
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):169-75. doi: 10.1016/j.ejogrb.2008.02.022. Epub 2008 Apr 28.
2
Intrauterine devices and intrauterine systems.宫内节育器和宫内节育系统
Hum Reprod Update. 2008 May-Jun;14(3):197-208. doi: 10.1093/humupd/dmn003. Epub 2008 Apr 9.
3
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.尽管使用左炔诺孕酮宫内节育系统进行宫内孕激素治疗，非典型子宫内膜增生仍进展为腺癌。
Obstet Gynecol. 2008 Feb;111(2 Pt 2):547-9. doi: 10.1097/01.AOG.0000300716.84819.c6.
4
Contraceptive efficacy of intrauterine devices.宫内节育器的避孕效果
Am J Obstet Gynecol. 2008 Mar;198(3):248-53. doi: 10.1016/j.ajog.2007.10.787. Epub 2008 Jan 25.
5
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.左炔诺孕酮宫内节育器对子宫腺肌病患者的临床疗效。
Am J Obstet Gynecol. 2008 Apr;198(4):373.e1-7. doi: 10.1016/j.ajog.2007.10.798. Epub 2008 Feb 21.
6
Subject and clinician experience with the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的受试者及临床医生经验
Contraception. 2008 Jan;77(1):22-9. doi: 10.1016/j.contraception.2007.09.006. Epub 2007 Nov 26.
7
Intrauterine contraception as an alternative to interval tubal sterilization.宫内避孕作为间隔期输卵管绝育术的替代方法。
Contraception. 2008 Jan;77(1):6-9. doi: 10.1016/j.contraception.2007.09.012. Epub 2007 Nov 26.
8
Retained hormone release capsule following removal of Mirena intrauterine system.
BJOG. 2008 Jan;115(1):130-1. doi: 10.1111/j.1471-0528.2007.01578.x.
9
A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.一项关于在接受他莫昔芬治疗的女性中使用左炔诺孕酮宫内节育系统进行预防的随机对照试验。
BJOG. 2007 Dec;114(12):1510-5. doi: 10.1111/j.1471-0528.2007.01545.x.
10
The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.左炔诺孕酮宫内节育系统：避孕及非避孕用途的最新综述
Clin Obstet Gynecol. 2007 Dec;50(4):886-97. doi: 10.1097/GRF.0b013e318159c0d9.
Zotero 插件